Advances in Genetic Obesity Management Across Syndromic and Monogenic Obesity

Join us for a live symposium on genetic obesity disorders. Experts will provide updates on management including appropriate use of setmelanotide. 

This program is being held in conjunction with ObesityWeek2022.

Agenda

2:45- 3:15 PM PST  Registration

3:15- 4:45 PM PST  Program

  • Overview of Genetic Obesity Disorders
  • Current and Emerging Evidence for MC4R Agonist
  • Review of Clinical Efficacy, Safety Data, and Role in Treatment of Genetic Obesity
  • Holistic Management of Genetic Obesity
  • Patient Case Vignettes
  • Closing Remarks, Postactivity Outcomes Polling
  • Question and Answer Session

Events

Date / Time
Event Details

Faculty

Faculty
Stephanie Sisley, MD

Assistant Professor
Department of Pediatrics
Baylor College of Medicine
Houston, Texas

Faculty
Fatima Cody Stanford, MD, MPH, MPA, MBA

Associate Professor
Departments of Medicine and Pediatrics
Harvard Medical School
Obesity Medicine Physician Scientist
Neuroendocrine Unit and Pediatrics
Endocinology
Department of Medicine
Massachusetts General Hospital
Boston, Massachusetts

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in recognizing the genetic causes of severe, early-onset obesity and implementing an individualized approach to manage long-term weight loss in both adults and children.

Target Audience
The target audience for the education are endocrinologists and obesity specialists, physicians, nurse practitioners, and physician assistants/physician associates.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Recognize clinical features that warrant further diagnostic workup for rare genetic causes of severe childhood obesity 
  • Apply strategies that support patients with genetic obesity and their families
  • Evaluate the current clinical efficacy and safety evidence for MC4R agonist treatment in the management of genetic obesity
  • Identify patients who would benefit from setmelanotide treatment as part of the holistic management of genetic obesity

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for maximum of 1.5 hours of AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.